Loading clinical trials...
Loading clinical trials...
The goal of the proposed research is to investigate the molecular mechanisms of racial disparity in Barrett's esophagus (BE), the premalignant lesion of esophageal adenocarcinoma. Specifically, the in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
NCT05745857 · Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, and more
NCT06523374 · Barrett's Esophagus, Esophageal Adenocarcinoma
NCT02616302 · Gastroesophageal Reflux Disease (GERD)
NCT04191551 · Gastric Cancer, Intestinal Metaplasia of Gastric Mucosa, and more
NCT06071845 · Barrett Esophagus, Barretts Esophagus With Dysplasia, and more
University of North Carolina Chapel Hill
Chapel Hill, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions